VOGLUS 0.2

Composition

Voglibose 0.2 mg

Uses of VOGLUS 0.2

Type 2 diabetes mellitus: to control post‑prandial (after meals) blood glucose, usually as add‑on to diet/exercise and/or other antidiabetic medicines.

• •Controls post‑meal blood sugar
• •Helps improve HbA1c when added to other therapy
• •Works locally in gut with minimal systemic absorption
• •Useful when diet/exercise alone are insufficient

How it works

Voglibose is an alpha‑glucosidase inhibitor that delays digestion and absorption of carbohydrates in the intestine. This reduces the rise in blood glucose after meals and helps improve overall glycaemic control.

Directions for use

Oral tablet. Take as prescribed, typically just before the start of each main meal (or with the first bite). Follow diet and exercise advice; do not skip meals if used with other antidiabetics. If a dose is missed, take with the next meal; do not double dose.

Side effects

Common side effects of VOGLUS 0.2 may include:

• •Flatulence
• •abdominal pain
• •diarrhoea
• •bloating
• •nausea

Warnings & precautions

Use only in type 2 diabetes (not for type 1 diabetes or diabetic ketoacidosis). Caution in patients with gastrointestinal disorders (e.g., inflammatory bowel disease, intestinal obstruction, chronic intestinal diseases), liver impairment, or elderly. When used with insulin/sulfonylureas, hypoglycaemia may occur—treat low sugar with oral glucose/dextrose (table sugar may be less effective due to delayed sucrose breakdown). Monitor blood glucose and HbA1c regularly; stop and seek medical advice if severe abdominal symptoms occur.